Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1979 Jun 30;1(6180):1757–1760. doi: 10.1136/bmj.1.6180.1757

An epidemiological study of oral contraceptives and breast cancer

M P Vessey, Richard Doll, Keena Jones, Klim McPherson, D Yeates
PMCID: PMC1599397  PMID: 466211

Abstract

During 1968-77, 707 women aged 16-50 years with newly diagnosed breast cancer and 707 matched controls were interviewed at eight teaching hospitals in London and Oxford about their use of oral contraceptives. Eighty-six of the patients with breast cancer were matched with controls with gall-bladder disease; these subjects were omitted from the main analyses, which thus related to 621 case-control pairs.

The results were reassuring. A few statistically significant differences in oral contraceptive use were found between the breast cancer and control groups, but the data were subdivided in many ways, so that some “significant” differences would have been expected to occur by chance. The only subgroup in which the evidence for a positive association between pill use and breast cancer was at all convincing comprised women aged 46-50 years, but trends in those aged 41-45 were by and large in the opposite direction and results of combined analysis gave no cause for concern.

Information on clinical stage was available for 487 patients with breast cancer treated before the end of 1975. Those who had never used oral contraceptives had appreciably more advanced tumours at presentation than those who had been using the pill during the year before detection of the lump, while past users of the pill occupied an intermediate position. This difference in staging was reflected in the pattern of survival. Oral contraceptives may have had a beneficial effect on tumour growth and spread, though diagnostic bias could not be definitely excluded.

Full text

PDF
1760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arthes F. G., Sartwell P. E., Lewison E. F. The pill, estrogens, and the breast. Epidemiologic aspects. Cancer. 1971 Dec;28(6):1391–1394. doi: 10.1002/1097-0142(197112)28:6<1391::aid-cncr2820280609>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  2. Breslow N. E., Day N. E., Halvorsen K. T., Prentice R. L., Sabai C. Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol. 1978 Oct;108(4):299–307. doi: 10.1093/oxfordjournals.aje.a112623. [DOI] [PubMed] [Google Scholar]
  3. Brinton L. A., Williams R. R., Hoover R. N., Stegens N. L., Feinleib M., Fraumeni J. F., Jr Breast cancer risk factors among screening program participants. J Natl Cancer Inst. 1979 Jan;62(1):37–44. [PubMed] [Google Scholar]
  4. Fasal E., Paffenbarger R. S., Jr Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst. 1975 Oct;55(4):767–773. doi: 10.1093/jnci/55.4.767. [DOI] [PubMed] [Google Scholar]
  5. Henderson B. E., Powell D., Rosario I., Keys C., Hanisch R., Young M., Casagrande J., Gerkins V., Pike M. C. An epidemiologic study of breast cancer. J Natl Cancer Inst. 1974 Sep;53(3):609–614. doi: 10.1093/jnci/53.3.609. [DOI] [PubMed] [Google Scholar]
  6. Kelsey J. L., Holford T. R., White C., Mayer E. S., Kilty S. E., Acheson R. M. Oral contraceptives and breast disease. An epidemiological study. Am J Epidemiol. 1978 Mar;107(3):236–244. doi: 10.1093/oxfordjournals.aje.a112530. [DOI] [PubMed] [Google Scholar]
  7. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  8. Ory H., Cole P., MacMahon B., Hoover R. Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med. 1976 Feb 19;294(8):419–422. doi: 10.1056/NEJM197602192940804. [DOI] [PubMed] [Google Scholar]
  9. Paffenbarger R. S., Jr, Fasal E., Simmons M. E., Kampert J. B. Cancer risk as related to use of oral contraceptives during fertile years. Cancer. 1977 Apr;39(4 Suppl):1887–1891. doi: 10.1002/1097-0142(197704)39:4+<1887::aid-cncr2820390822>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  10. Sartwell P. E., Arthes F. G., Tonascia J. A. Exogenous hormones, reproductive history, and breast cancer. J Natl Cancer Inst. 1977 Dec;59(6):1589–1592. doi: 10.1093/jnci/59.6.1589. [DOI] [PubMed] [Google Scholar]
  11. Spencer J. D., Millis R. R., Hayward J. L. Contraceptive steroids and breast cancer. Br Med J. 1978 Apr 22;1(6119):1024–1026. doi: 10.1136/bmj.1.6119.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Thomas D. B. Role of exogenous female hormones in altering the risk of benign and malignant neoplasms in humans. Cancer Res. 1978 Nov;38(11 Pt 2):3991–4000. [PubMed] [Google Scholar]
  13. Vessey M. P., Doll R., Jones K. Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet. 1975 Apr 26;1(7913):941–943. doi: 10.1016/s0140-6736(75)92005-x. [DOI] [PubMed] [Google Scholar]
  14. Vessey M., Doll R., Peto R., Johnson B., Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. doi: 10.1017/s0021932000010890. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES